Back
Royal Bank of Canada Vs. Novartis AG Industry Stock Comparison
Buy
64
RY
Royal Bank of Canada
Last Price:
$115.82
Seasonality Move:
2.92%
Buy
73
NVSEF
Novartis AG
Last Price:
$116.60
Seasonality Move:
6.56%
Buy
64
Royal Bank of Canada (RY)
is a Buy
Is Royal Bank of Canada a Buy, Sell or Hold?
-
The current Royal Bank of Canada [RY] share price is $113.60. The Score for RY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
RY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $116.60. The Score for NVSEF is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RY Stock Price Chart
What is Royal Bank of Canada's stock price today?
-
The Royal Bank of Canada share price today is $113.60The current trend is relatively stagnant and RY is experiencing slight buying pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $116.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
RY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.68 | Sell |
Relative Strength Index (14 RSI): | 45.75 | Sell |
Chaikin Money Flow: | 290799 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (112.21 - 119.11) | Sell |
Bollinger Bands (100): | (116.76 - 124.58) | Sell |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.49 | Buy |
Relative Strength Index (14 RSI): | 61.26 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (106.5 - 113.3) | Buy |
Bollinger Bands (100): | (98.59 - 109.27) | Buy |
RY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.3 | Buy |
20-day SMA: | 114.67 | Sell |
50-day SMA: | 118.1 | Sell |
200-day SMA: | 117.46 | Sell |
8-day EMA: | 113.2 | Buy |
20-day EMA: | 114.49 | Sell |
50-day EMA: | 117.19 | Sell |
200-day EMA: | 115.88 | Sell |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.01 | Buy |
20-day SMA: | 110.7 | Buy |
50-day SMA: | 105.61 | Buy |
200-day SMA: | 106.68 | Buy |
8-day EMA: | 111.08 | Buy |
20-day EMA: | 110.03 | Buy |
50-day EMA: | 107.18 | Buy |
200-day EMA: | 104.62 | Buy |
Royal Bank of Canada Earnings Growth & RY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.13 per share, an increase this year of $0.88 per share, and an increase next year of $0.66 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Royal Bank of Canada Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |